⚠Due to planned maintenance you will experience short (<30 min) downtime between 08:00 - 08:30 CET.
Operational information
This data is publicly available. Parent page : ION-8139
Operational data for Matchis Foundation - ION-8139 | |
---|---|
Organisation Overview | |
The information has been reviewed in year : | 2025 |
Issuing organisation Number (ION) | ION-8139 The Issuing Organisation Number of a organisation, this is globally unique number, as issued by the ICCBBA. |
Time zone | Europe/Amsterdam (GMT+01:00) The timezone in which this organisation operates. |
Business hours | 8:30 - 17:00 The daily hours in which this organisation operates. |
Work schedule | MON-FRI The normal work week in which this organisation operates. |
Organisation closures | For all organisation closures, please see the WMDA Calendar. |
Donor ID example | NLxxxxxxxx or NLxxxxxxxD or 8139 xxxx xxxx xxxx xxx ID to be expected on paperwork, samples, and products. |
Preliminary Search | |
Requires preliminary search request form | No If yes, form required can be found on the Documents Page. |
Extended Typing | |
Typing options available for request | HR,LR,IR, A,B,C,DR,DP,DQ,DRB1 Please note special requirements listed |
Requires organisation specific typing request form | No If yes, form required can be found on the Documents Page. |
Number of days donor is reserved for a patient after a request | 90 days |
Verification Typing | |
Maximum blood volume allowed | 100 |
Requires organisation specific typing request form | No If yes, form required can be found on the Documents Page. |
IDM testing performed at verification | Yes |
Number of days donor is reserved for a patient after a request | 90 days |
Sibling Typing | |
Registry is willing to arrange sibling typings | Yes |
If yes, procedure to apply for sibling typings | By email request; then we will ask you to complete WMDA forms (they will be sent to you) |
Workup Request | |
Product dosage limit | depends on donor Number of donor cells allowed based on recipient weight. |
Requires patient to meet certain standards in order to proceed with collection | Yes Organisation may or may not allow donor collections for some patients. |
Patient physician must report the following in order to proceed with collection | See minimal criteria document Must provide additional information to organisation. |
Requires organisation specific work up forms | No If yes, form(s) required can be found on the Documents Page. |
Workup IDM completed 30 days prior to collection | Yes Donor IDM results must be performed within 30 days of collection date to be valid and allow the collection to proceed. |
Medical Health Questionnaire example available | Yes If yes, the example can be found on the Documents Page. |
Post-Transplant | |
Subsequent donation policy | Allowed, under supervision of Medical Advisory Board |
Anonymous contact allowed | Anonymous postcards or letters |
Direct contact allowed | NO |
Gift exchange allowed | YES, small presents and not valuable |
Cord blood contact allowed | N.A. |
IDM
IDM | Tested | Method | Days between test and sampling/workup |
---|---|---|---|
ALT/ASTALT/AST ratio, De-Ritis-Quotient | Yes | ||
ChagasChagas, T. cruzi | On request | serology | at WU |
CMV IgGCytomegalovirus (CMV) Antibody testing IgG | Yes | Chemiluminescence Immunosorbent (CLIA) - Architect | |
CMV IgMCytomegalovirus (CMV) Antibody testing IgM | On request | Chemiluminescence Immunosorbent (CLIA) - Architect | at CT / WU |
CMV TotalCytomegalovirus Total | No | ||
EBV IgGEpstein-Barr Virus Antibody testing IgG | Yes | Chemiluminescence Immunosorbent (CLIA) - Liaison | at WU |
EBV IgMEpstein-Barr Virus Antibody testing IgM | On request | Chemiluminescence Immunosorbent (CLIA) - Liaison | at WU |
HAV (NAT)Anti-hepatitis A virus nucleic acid testing | - | ||
HBV (NAT)Hepatitis B nucleic acid testing | Yes | Quantitative RT-PCR | |
HBc AbHepatitis B core antibody testing | Yes | Chemiluminescence Immunosorbent (CLIA) | |
HBs AgHepatitis B Surface antigen testing | Yes | Chemiluminescence Immunosorbent (CLIA) - Architect | |
HCV (NAT)Hepatitis C nucleic acid testing | Yes | Quantitative RT-PCR - Cobas Taqman | |
HCV AbHepatitis C antibody testing | Yes | Chemiluminescence Immunosorbent (CLIA) | |
HEV (NAT)Hepatitis E Virus nucleic acid testing | Yes | Qualitative RT-PCR | at WU |
HIV (NAT)Human Immunodeficiency Virus nucleic acid testing | Yes | Quantitative RT-PCR | |
HIV-1 AbHuman Immunodeficiency Virus HIV-1 antibody testing | Yes | Chemiluminescence Immunosorbent (CLIA) - Architect - HIV score blot | |
HIV-2 AbHuman Immunodeficiency Virus HIV-2 antibody testing | Yes | Chemiluminescence Immunosorbent (CLIA) - Architect - HIV score blot | |
HIV p24Human Immunodeficiency Virus p24 antigen testing | Yes | Chemiluminescence Immunosorbent (CLIA) - Architect - HIV score blot - HIV duo ultra (VIDAS) | at CT/WU |
HTLV-IHuman T-Lymphotropic Virus type I testing | Yes | Chemiluminescence Immunosorbent (CLIA) - Architect - Immunoblot | |
HTLV-IIHuman T-Lymphotropic Virus type II testing | Yes | Chemiluminescence Immunosorbent (CLIA) - Architect - Immunoblot | |
MalariaMalaria | On request | serology or PCR | at WU |
HSVHerpes Simplex Virus | On request | serology or PCR - Diasorin Liaison XL HSV IgG | at WU |
STSSerological tests for syphilis | Yes | Chemiluminescence Immunosorbent (CLIA) - TP Architect - lues blot (INNO-LIA innogenetics ) RPR titratie | |
STS FTA-ABSSerological test for syphilis | On request | only at positive STS serology - TP Architect - lues blot Fujiredio | |
ToxoplasmosisToxoplasmosis | Yes | Chemiluminescence Immunosorbent (CLIA) | at WU |
VZVVaricella Zoster Virus | On request | Chemiluminescence Immunosorbent (CLIA) - Diasorin Liaison XL VZV IgG | at WU |
WNV-NATWest Nile Virus nucleic acid testing | On request | at WU | |
Other tests performed | Yes | Denque NS1 Ag; Denque PCR, Zika PCR, Qfever phase 2 ab |
Regulatory information
The data provided on this page is updated by the organisations.
The WMDA makes no representations or express or implied warranties regarding any information on this page.
Use of any information provided on this site does not and is not intended to create a contractual or other relationship.
The WMDA makes no representations or express or implied warranties regarding any information on this page.
Use of any information provided on this site does not and is not intended to create a contractual or other relationship.
General | |
---|---|
The information has been reviewed in year : | 2025 |
Organisation name: | Matchis Foundation |
Organisation ION: | ION-8139 |
Country: | The Netherlands |
Year the registry started operations: | 1988 |
Products | comment | |
---|---|---|
Do you provide HPC, Marrow? | yes | |
Do you provide HPC, Apheresis? | yes | |
Do you provide HPC, Cord Blood? | no | Requests for Dutch CBU is forwarded to Sanquin ION-1131 |
Do you provide MNC, Apheresis? | yes | |
Do you provide NC, Whole Blood? | no |
Product quantity | ||
---|---|---|
Data valid for year | 2024 | |
Number of products | National | International |
HPC, Marrow products: | 2 | 18 |
HPC, Apheresis: | 21 | 136 |
HPC, Cord: | 0 | 0 |
License | |
---|---|
Organisation is licensed/accredited by the Health Authority: | yes |
Comment: | Tissue establishment license |
Name of Health Authority: | Ministry of Health, Welfare, Sport; Inspected by IGJ |
Date of last inspection: | 2024/01 |
Link to website of Health Authority: | https://www.government.nl/ministries/ministry-of-health-welfare-and-sport |
Can you provide the Legal documentation from the Competent Authority that your organisation is allowed to operate as a registry ? | yes |
The registry is accredited by any other organisation: | yes |
If yes, by which organisation? | ISO27001/NEN7510 certification - data protection |
Donor policy | |
---|---|
All donors are unpaid volunteers: | yes |
All donors are informed about donation process and associated risks: | yes |
Donors sign a valid informed consent to donate in the presence of a medical doctor/health care personnel/registry staff: | yes |
The registry has systems in place to protect and control access to donor/patient records: | yes |
The registry maintains donor anonymity: | yes |
The registry has detailed donor evaluation and exclusion criteria in place: | yes |
The registry has donor evaluation and exclusion criteria that do meet or exceed the WMDA guidelines: | yes |
Regulatory information section 2
Relevant documents will be uploaded by the organisation to the documents page.Testing | |
---|---|
The physical and medical exam at donor workup is performed by a medical doctor: | yes |
All donor testing (at workup) for infectious disease is performed in a laboratory certified/licensed by a Competent Authority: | yes |
HLA typing for patient specific request is performed in an appropriately accredited laboratory: | yes |
Sterility testing is performed on the adult donor product: | yes |
Sterility testing is performed on the cord blood product: | |
Screening questionnaire to exclude communicable disease: | yes |
Screening questionnaire to exclude donors with 'high risk' lifestyles: | yes |
Donor reliability identified by a medical doctor: | yes |
Donor clearance to donate is confirmed by a medical doctor, following as a minimum the donor exclusion criteria in Annex 1 of EU Directive 2006/17/EC : | yes |
Customs regulations | |
---|---|
Are there any customs regulations to follow or customs paperwork required needed to import cell products into the country of the affiliated transplant centres? | No specific custom regulation for import cells into the Netherlands |
Are there any customs regulations to follow or customs paperwork required needed to export cell products from the country of the affiliated organisation? | Standard procedure for export: Prior to shipment notification to customs and security; to accompany the product: Collection report, collection details, Transport Audit form, Transplant report, confidentiality policy, if for NMDP: IDM, declaration of donor eligibility |
Are there any import national regulations to follow or paperwork required needed to import the cell products into the country of the affiliated transplant centre? | Matchis is licensed to import HPC into the Netherlands and follows strict Matchis safety policies |
Are there any export regulations to follow or paperwork required needed to export cell products from the country of the affiliated organisation? |
Reporting of Serious Adverse Events | |
---|---|
Please indicate which of the following schemes for reporting Serious Adverse Events relating to either the Donor or the product the Registry participates in: | |
- Mandatory National Reporting Scheme | yes |
- Voluntary National Reporting Scheme | |
- WMDA SEAR/SPEAR Reporting Scheme | yes |
The registry will notify the receiving Registry within 24 hours of receiving information relating to any serious adverse event that could be considered to affect the patient receiving the product: | yes |
Quality management | |
---|---|
The organisation does maintain Standard Operating Procedures for its work: | yes |
Please indicate if your organisation/country has any specific requirements that should be communicated in advance to the requesting entity (e.g., financial sanctions, specific regulatory forms, etc.) : | |
Donor records relating to the medical exam and cell product collection process are the following number(s) of year(s) retained: | 30 |